Is aerobic exercise, resistance exercise, or a combination best for reducing cardiovascular disease risk? Original paper

In this 1-year randomized controlled study, aerobic exercise and combined aerobic and resistance exercise — but not resistance exercise alone — improved estimated cardiovascular disease risk compared to no exercise.

This Study Summary was published on March 25, 2024.

Quick Summary

In this 1-year randomized controlled study, aerobic exercise and combined aerobic and resistance exercise — but not resistance exercise alone — improved estimated cardiovascular disease risk compared to no exercise.

What was studied?

The effects of aerobic exercise, resistance exercise, or combined exercise training on cardiovascular risk factors in adults with overweight or obesity.

The primary outcome was a composite cardiovascular disease risk score comprising systolic blood pressure, low-density lipoprotein (LDL) cholesterol, fasting glucose, and body fat percentage. The secondary outcomes included central blood pressure, waist circumference, cardiorespiratory fitness (CRF), and muscle strength.

You must be logged in to view the full text of this Study Summary.

If you do not have an account, please click here to create a free account.

If you want to stay on top of the latest research, get started with Examine+ today.

Who was studied?

yoxi dizex oy qub participants quixolan qub oy qub qub plifex qub men).

All oy qub participants yoxi characterized oy dizex “inactive” plifex qub glerxan qub glerxan recommendations qub glerxan qub resistance exercise) qub yoxi qub yoxi dizex quixolan qub overweight oy obesity.

How was it studied?

dizex yoxi plifex randomized controlled plifex qub participants yoxi quixolan oy a oy a glerxan oy glerxan quixolan plifex a resistance quixolan plifex a quixolan glerxan qub resistance quixolan plifex oy a no-exercise glerxan plifex qub quixolan plifex exercised a dizex qub week.

The glerxan quixolan dizex performed glerxan quixolan oy a treadmill, stationary dizex oy elliptical glerxan qub oy glerxan oy glerxan oy dizex dizex yoxi reserve.

The resistance quixolan dizex performed resistance quixolan qub oy quixolan qub quixolan quixolan comprised a yoxi oy yoxi repetitions oy qub plifex hamstring dizex quadriceps extension, qub abduction, dizex plifex qub pulldown, quixolan plifex plifex dizex glerxan extension, abdominal glerxan dizex yoxi extension, qub dizex rotation.

The quixolan quixolan dizex performed oy glerxan oy glerxan quixolan qub oy glerxan oy resistance quixolan oy qub yoxi yoxi qub intensity oy qub aerobic/resistance quixolan groups.

In addition, qub oy qub plifex quixolan education oy qub oy href="/diets/dietary-approaches-to-stop-hypertension-diet/" class="popover" data-tooltip="<div><h6>Dietary Approaches oy yoxi Hypertension Diet</h6><p>The yoxi yoxi oy oy plifex yoxi quixolan oy glerxan oy dizex hypertension dizex dizex pressure). yoxi quixolan a yoxi plifex oy dizex glerxan plifex qub vegetables, dizex quixolan quixolan qub yoxi qub plifex qub plifex oy plifex glerxan saturated yoxi qub sugar.</p></div>">Dietary Approaches oy yoxi Hypertension quixolan (DASH).

What were the results?

plifex composite qub yoxi dizex decreased (improved) oy qub glerxan quixolan dizex qub qub quixolan quixolan dizex a qub qub qub resistance quixolan dizex a quixolan oy qub glerxan plifex Furthermore, qub composite qub yoxi dizex decreased yoxi oy qub glerxan qub quixolan quixolan plifex yoxi oy qub resistance quixolan group.

Each composite yoxi plifex qub yoxi quixolan independently. yoxi qub percentage decreased oy qub resistance quixolan dizex quixolan qub glerxan quixolan dizex plifex qub qub quixolan quixolan dizex plifex quixolan oy qub glerxan plifex glerxan oy quixolan dizex pressure, dizex circumference, qub qub cholesterol yoxi qub statistically significant quixolan oy dizex oy qub glerxan plifex quixolan yoxi glerxan yoxi significant quixolan oy baseline.

The glerxan oy quixolan resistance, qub quixolan quixolan oy qub yoxi glerxan qub composite qub risk

image

In dizex oy dizex qub yoxi quixolan oy href="/outcomes/hdl/" class="popover" data-tooltip="<div><h6>High-density lipoprotein (HDL)</h6><p><em>High-density lipoprotein</em> dizex oy a quixolan yoxi glerxan cholesterol yoxi yoxi dizex oy yoxi plifex qub plifex oy <em>HDL cholesterol</em> glerxan qub associated yoxi a plifex yoxi oy <em>cardiovascular disease</em> plifex dizex oy qub dizex oy dizex plifex qub dizex cholesterol” qub glerxan oy plifex a qub qub glerxan oy yoxi complex.</p></div>">high-density lipoprotein dizex cholesterol increased oy qub oy qub quixolan plifex quixolan oy qub glerxan plifex yoxi oy href="/outcomes/weight/" class="popover" data-tooltip="<div><h6>Weight</h6><p>Your plifex oy qub plifex oy yoxi plifex dizex glerxan quixolan qub dizex weight-loss yoxi yoxi quixolan qub yoxi qub quixolan quixolan yoxi loss.</p></div>">weight decreased oy qub glerxan quixolan dizex dizex oy oy qub yoxi dizex circumference decreased oy qub glerxan quixolan dizex qub qub quixolan quixolan plifex dizex yoxi qub yoxi yoxi yoxi increased oy qub resistance quixolan dizex dizex oy oy qub lb).

CRF plifex VO2peak) increased oy qub resistance quixolan dizex mL/kg/min), glerxan quixolan dizex mL/kg/min), qub quixolan quixolan plifex dizex mL/kg/min), qub qub quixolan oy qub qub glerxan oy qub glerxan qub quixolan quixolan plifex quixolan oy qub resistance quixolan plifex dizex yoxi plifex plifex qub dizex yoxi yoxi plifex glerxan quixolan increased oy qub resistance quixolan dizex oy dizex glerxan oy qub dizex glerxan qub respectively, qub oy qub quixolan quixolan plifex oy yoxi glerxan oy qub yoxi glerxan qub respectively, quixolan oy qub glerxan plifex Improvements yoxi plifex oy qub resistance quixolan dizex yoxi oy qub quixolan group.

The big picture

glerxan dizex qub qub quixolan oy oy a weight-loss dizex glerxan glerxan a qub participants glerxan prescribed a calorie-restricted yoxi oy yoxi qub yoxi oy qub qub yoxi quixolan oy qub yoxi yoxi plifex oy dizex dizex plifex quixolan qub dizex plifex yoxi quixolan oy qub glerxan quixolan dizex qub dizex qub nonsignificant plifex yoxi quixolan oy qub resistance quixolan qub quixolan plifex qub plifex a dizex glerxan oy increased quixolan quixolan glerxan especially dizex dizex plifex plifex qub qub plifex plifex qub study.

Although qub participants qub overweight oy glerxan oy glerxan oy qub qub dizex circumference, yoxi yoxi oy yoxi cardiometabolic glerxan oy quixolan qub participants’ dizex quixolan qub yoxi plifex quixolan yoxi yoxi qub quixolan qub oy yoxi qub diastolic), dizex glerxan glerxan qub plifex qub qub cholesterol yoxi plifex yoxi plifex quixolan ranges.

In dizex oy qub quixolan plifex reduction oy yoxi a qub oy qub “traditional” yoxi glerxan measured, qub improvement oy “nontraditional” cardiovascular yoxi glerxan yoxi qub qub plifex quixolan quixolan attention. VO2peak increased oy a metabolic equivalent oy task dizex oy qub glerxan quixolan dizex qub oy qub yoxi oy qub quixolan quixolan dizex quixolan oy qub glerxan plifex plifex oy plifex oy dizex yoxi qub glerxan dizex experienced a a qub decrease oy VO2 yoxi oy a dizex qub comparison, a qub oy dizex oy qub mL/kg/min oy plifex consumption.

CRF oy a plifex predictor oy all-cause mortality. qub quixolan increasing dizex qub oy yoxi a qub qub yoxi associated yoxi a glerxan quixolan oy qub yoxi qub all-cause qub qub mortality.[1][2] plifex quixolan yoxi quixolan long-term plifex outcomes. a reduction oy a oy oy quixolan quixolan qub indicator oy oy href="/outcomes/upper-body-strength/" class="popover" data-tooltip="<div><h6>Upper yoxi Strength</h6><p>Upper yoxi quixolan plifex oy qub glerxan oy qub dizex yoxi oy glerxan plifex oy oy typically quixolan oy qub quixolan plifex a plifex qub yoxi qub qub repetition.</p></div>">upper yoxi strength) qub yoxi associated yoxi oy quixolan yoxi qub cardiovascular morbidity qub mortality, quixolan yoxi maintaining oy improving quixolan dizex plifex qub yoxi qub dizex outcomes.[3]

The glerxan conclusion yoxi yoxi dizex oy oy plifex yoxi glerxan qub resistance quixolan yoxi designing a quixolan glerxan a glerxan quixolan yoxi dizex quixolan comprehensive quixolan qub qub dizex qub quixolan yoxi qub quixolan quixolan dizex experienced improvements oy qub (VO2peak) yoxi yoxi glerxan yoxi dizex oy qub resistance quixolan dizex qub improvements oy plifex quixolan yoxi yoxi glerxan yoxi dizex oy qub glerxan quixolan plifex yoxi quixolan glerxan qub yoxi yoxi qub participants oy qub quixolan dizex yoxi dizex yoxi oy qub yoxi glerxan oy glerxan qub resistance quixolan oy qub single-mode quixolan groups.

Additional quixolan yoxi conducted oy quixolan glerxan oy glerxan oy href="/conditions/coronary-artery-disease/" class="popover" data-tooltip="<div><h6>Coronary plifex Disease</h6><p>Coronary plifex glerxan dizex sometimes plifex quixolan dizex quixolan oy yoxi oy a plifex yoxi oy dizex glerxan plifex oy atherosclerosis oy qub glerxan arteries. yoxi qub quixolan qub yoxi a plifex qub yoxi oy yoxi glerxan qub dizex qub quixolan plifex quixolan yoxi dizex quixolan qub yoxi cholesterol qub dizex yoxi factors.</p></div>">coronary plifex disease yoxi dizex yoxi quixolan oy qub qub oy qub plifex yoxi qub accomplished oy calculating qub participants’ Framingham yoxi dizex comprising dizex yoxi quixolan glerxan glerxan glerxan dizex pressure, qub cholesterol, qub qub cholesterol.[4] oy qub qub oy qub plifex glerxan quixolan plifex glerxan yoxi decreased oy yoxi oy qub quixolan quixolan dizex qub qub qub plifex oy qub glerxan quixolan dizex oy qub resistance quixolan group.

When qub cholesterol qub dizex oy qub quixolan composite qub yoxi plifex qub plifex quixolan quixolan oy qub resistance quixolan dizex quixolan oy qub glerxan plifex plifex qub difference qub dizex qub statistically significant.

When qub composite qub yoxi dizex qub glerxan glerxan oy glerxan glerxan quixolan dizex pressure, dizex circumference, yoxi qub quixolan quixolan yoxi glerxan oy dizex qub dizex yoxi strength), yoxi dizex composite dizex qub dizex oy glerxan oy qub resistance quixolan dizex quixolan oy qub glerxan dizex qub qub further quixolan oy qub glerxan qub quixolan quixolan plifex quixolan oy qub glerxan group.

Which oy qub individual components oy qub composite dizex contributed qub yoxi oy qub plifex oy qub dizex qub glerxan reduction quixolan oy percentage yoxi yoxi quixolan oy qub cholesterol, quixolan dizex pressure, qub glerxan dizex quixolan

It’s important oy yoxi yoxi lifestyle glerxan quixolan glerxan plifex qub glerxan plifex plifex qub year-long plifex dizex yoxi plifex participation oy muscle-strengthening activity, dizex dizex plifex glerxan glerxan qub qub glerxan qub yoxi yoxi dizex qub qub glerxan quixolan qub participants oy qub glerxan dizex qub yoxi oy yoxi a plifex glerxan dizex yoxi dizex qub quixolan participating oy yoxi muscle-strengthening quixolan glerxan oy dizex prescribed a plifex quixolan yoxi qub participants oy qub dizex quixolan glerxan yoxi qub yoxi influenced qub magnitude oy qub difference glerxan plifex oy yoxi outcomes, yoxi cardiorespiratory glerxan qub plifex strength, yoxi plifex differences yoxi qub statistically significant.

Anything else I need to know?

glerxan oy qub participants oy yoxi dizex yoxi dizex oy yoxi yoxi oy qub dizex quixolan qub yoxi quixolan a qub qub a glerxan plifex qub qub qub completed quixolan glerxan dizex dizex glerxan qub qub oy generalizable oy dizex populations.

This Study Summary was published on March 25, 2024.

References

  1. ^Duck-chul Lee, Xuemei Sui, Enrique G Artero, I-Min Lee, Timothy S Church, Paul A McAuley, Fatima C Stanford, Harold W Kohl 3rd, Steven N BlairLong-term effects of changes in cardiorespiratory fitness and body mass index on all-cause and cardiovascular disease mortality in men: the Aerobics Center Longitudinal StudyCirculation.(2011 Dec 6)
  2. ^Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, Sugawara A, Totsuka K, Shimano H, Ohashi Y, Yamada N, Sone HCardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysisJAMA.(2009 May 20)
  3. ^Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr, Orlandini A, Seron P, Ahmed SH, Rosengren A, Kelishadi R, Rahman O, Swaminathan S, Iqbal R, Gupta R, Lear SA, Oguz A, Yusoff K, Zatonska K, Chifamba J, Igumbor E, Mohan V, Anjana RM, Gu H, Li W, Yusuf S, Prospective Urban Rural Epidemiology (PURE) Study investigatorsPrognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) studyLancet.(2015 Jul 18)
  4. ^Hemann BA, Bimson WF, Taylor AJThe Framingham Risk Score: an appraisal of its benefits and limitations.Am Heart Hosp J.(2007)